Atlas Trials

SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2

Clinical trial NCT02592421 · COMPLETED

Trial details

NCT number
NCT02592421
Sponsor
The University of Texas Health Science Center at San Antonio
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type II Diabetes Mellitus
Start date
2015-10-23
Primary completion
2018-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.